Principal Investigators

    Professor Seth Love

    Institution

    University of Bristol

    Contact information of lead PI

    Country

    United Kingdom

    Title of project or programme

    The dynamic role of astrocyte secreted APO?4 in Alzheimer’s disease: investigations using human induced pluripotent stem cells

    Source of funding information

    Alzheimer's Society

    Total sum awarded (Euro)

    € 303,400

    Start date of award

    01/01/2016

    Total duration of award in years

    3

    Keywords

    Research Abstract

    The e4 allele of the APOE gene is a strong genetic risk factor for Alzheimer’s disease (AD). APOE has roles in neuronal homeostasis, regeneration and synaptogenesis, and in clearance of A? from the brain. APOE-dependent clearance of A? is partly mediated by astrocytes. APOE is required for their localization to A? plaques, and internalization and degradation of A?. APOE4 is less effective than other APOE isoforms in these and other roles that affect neuronal function. Assessment of the mechanisms of influence of APOE genotype on astrocyte function and neuronal interaction in AD has been limited by a lack of representative experimental models. We have generated a collection of human induced pluripotent stem cell (hiPSC) lines from human adult skin fibroblasts with different combinations of APOE alleles, from AD patients and controls. We are able to differentiate the hiPSCs into cholinergic or glutamatergic neurons or mature astrocytes, together providing a suitable human model to study the differential effects of APOE isoforms on astrocyte function and neuronal interaction in AD and control astrocytes and neurons. We will examine how APOE4 vs APOE3 isoforms influence the health, survival and function of neurons in normal conditions and also in the presence of A?. We will also examine the role of APOE in the cell-autonomous response of neurons to A?, the APOE-mediated support provided by astrocytes and in astrocytic clearance of A?, and explore some preliminary approaches to therapeutic targeting of these processes.

    Further information available at:

Types: Investments < €500k
Member States: United Kingdom
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF